Over 30s set to be offered the vaccine ‘within days’ after 40m Pfizer jabs deal

Leah Sinclair
·2-min read

Over 30s are set to be offered the Covid-19 vaccine in a matter of days, according to reports. 

The NHS will start inviting those in their thirties for the jab by the end of next week after securing 40 million Pfizer doses for Britain. 

Officials are close to finalising a deal to acquire tens of millions more doses of the vaccine in time for a third booster dose to be given to the elderly this autumn, the Sunday Times reports. 

Government sources told the paper that they hope to roughly double the UK’s original order of 40 million jabs.

If negotiations are successful, the extra stock may also be used for those in their twenties.

Watch: How do people feel about the AstraZeneca vaccine?

It comes as vaccine chiefs are said to be examining whether under-40s should not be given an alternative to the AstraZeneca jab amid blood clot fears. 

New data from the Medical Healthcare products and Regulatory Agency (MHRA) suggested the risk of forming a serious blood clot has jumped from one in 250,000 to around one in 126,600 in a fortnight.

Earlier this month, new UK guidance was issued recommending that people aged 18 to 29 should be offered the Pfizer or Moderna vaccines, as the benefits of the AstraZeneca jab for younger people may not surpass the risks.

The Joint Committee on Vaccination and Immunisation (JCVI) is considering whether a further change of policy is needed for older groups, and is currently examining the new data ahead the rollout to under-40s

The chance of dying from a blood clot after having the AZ jab in the UK is about one in one million - after 19 died from around 20million vaccinations.

More than half the UK population, or 33.5 million people, have received their first Covid-19 vaccine, with 12 million having received their second dose.

Brits in their 40s started receiving jabs earlier this month

Watch: Do coronavirus vaccines affect fertility?

Read More

Children ‘left behind’ in Covid-19 vaccination programme – JCVI expert

Alternatives to AZ jab ‘considered for under 40s’ amid rise in clots

‘AstraZeneca jab gives significant benefit against hospital admission’

TikTok and the virtual test drive: is this the future of car buying?